Therapeutic hypothermia in brain injuries and related diseases

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 5, Issue 2, 2011, Pages 155-164

  Kim, Jong Heon ^a   Lee, Jea Young ^a   Suk, Kyoungho ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Brain; Cannabinoid; Central nervous system; Hypothermia; Inflammation; Neuroinflammation

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 2 RECEPTOR; CANNABINOID 2 RECEPTOR AGONIST;

CEREBROVASCULAR ACCIDENT; COST OF ILLNESS; DECOMPRESSIVE CRANIECTOMY; DEVICE THERAPY; DRUG EFFECT; ENCEPHALITIS; HUMAN; INDUCED HYPOTHERMIA; MEDICAL INSTRUMENTATION; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; THERAPY EFFECT; TRAUMATIC BRAIN INJURY; TREATMENT DURATION; TREATMENT PLANNING; WARMING;

ANIMALS; BRAIN INJURIES; CANNABINOIDS; EQUIPMENT DESIGN; HUMANS; HYPOTHERMIA, INDUCED; TREATMENT OUTCOME;

EID: 79954453963     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221311795399219     Document Type: Review

References (169)

1. Bellamy R, Safar P, Tisherman SA, Basford R, Bruttig SP, Capone A, et al. Suspended animation for delayed resuscitation. Crit Care Med 1996; 24(2 Suppl): S24-47.
2. Liu L, Yenari MA. Therapeutic hypothermia: Neuroprotective mechanisms. Front Biosci 2007; 12: 816-25.
3. Slikker W 3rd, Desai VG, Duhart H, Feuers R, Imam SZ. Hypothermia enhances bcl-2 expression and protects against oxidative stress-induced cell death in Chinese hamster ovary cells. Free Radic Biol Med 2001; 31(3): 405-11.
4. D'Cruz BJ, Fertig KC, Filiano AJ, Hicks SD, DeFranco DB, Callaway CW. Hypothermic reperfusion after cardiac arrest augments brain-derived neurotrophic factor activation. J Cereb Blood Flow Metab 2002; 22(7): 843-51.
5. Sonna LA, Kuhlmeier MM, Khatri P, Chen D, Lilly CM. A microarray analysis of the effects of moderate hypothermia and rewarming on gene expression by human hepatocytes (HepG2). Cell Stress Chaperones 2010; 15(5): 687-702.
6. Morales DM, Marklund N, Lebold D, Thompson HJ, Pitkanen A, Maxwell WL, et al. Experimental models of traumatic brain injury: Do we really need to build a better mousetrap? Neuroscience 2005; 136(4): 971-89.
7. Kochanek PM, Clark RS, Ruppel RA, Adelson PD, Bell MJ, Whalen MJ, et al. Biochemical, cellular, and molecular mechanisms in the evolution of secondary damage after severe traumatic brain injury in infants and children: Lessons learned from the bedside. Pediatr Crit Care Med 2000; 1(1): 4-19.
8. Schofield PW, Logroscino G, Andrews HF, Albert S, Stern Y. An association between head circumference and Alzheimer's disease in a population-based study of aging and dementia. Neurology 1997; 49(1): 30-7.
9. Diller KR, Zhu L. Hypothermia therapy for brain injury. Annu Rev Biomed Eng 2009; 11: 135-62.
10. Clifton GL, Jiang JY, Lyeth BG, Jenkins LW, Hamm RJ, Hayes RL. Marked protection by moderate hypothermia after experimental traumatic brain injury. J Cereb Blood Flow Metab 1991; 11(1): 114-21.
11. Lyeth BG, Jiang JY, Liu S. Behavioral protection by moderate hypothermia initiated after experimental traumatic brain injury. J Neurotrauma 1993; 10(1): 57-64.
12. Dietrich WD, Alonso O, Busto R, Globus MY, Ginsberg MD. Posttraumatic brain hypothermia reduces histopathological damage following concussive brain injury in the rat. Acta Neuropathol 1994; 87(3): 250-8.
13. Wei EP, Hamm RJ, Baranova AI, Povlishock JT. The long-term microvascular and behavioral consequences of experimental traumatic brain injury after hypothermic intervention. J Neurotrauma 2009; 26(4): 527-37.
14. Jiang JY, Lyeth BG, Kapasi MZ, Jenkins LW, Povlishock JT. Moderate hypothermia reduces blood-brain barrier disruption following traumatic brain injury in the rat. Acta Neuropathol 1992; 84(5): 495-500.
15. Lotocki G, Vaccari JP, Perez ER, Sanchez-Molano J, Furones-Alonso O, Bramlett HM, et al. Alterations in blood-brain barrier permeability to large and small molecules and leukocyte accumulation after traumatic brain injury: Effects of post-traumatic hypothermia. J Neurotrauma 2009; 26(7): 1123-34.
16. Marion DW, White MJ. Treatment of experimental brain injury with moderate hypothermia and 21-aminosteroids. J Neurotrauma 1996; 13(3): 139-47.
17. Ma M, Matthews BT, Lampe JW, Meaney DF, Shofer FS, Neumar RW. Immediate short-duration hypothermia provides long-term protection in an in vivo model of traumatic axonal injury. Exp Neurol 2009; 215(1): 119-27.
18. Jia F, Mao Q, Liang YM, Jiang JY. Effect of post-traumatic mild hypothermia on hippocampal cell death after traumatic brain injury in rats. J Neurotrauma 2009; 26(2): 243-52.
19. Bayir H, Kochanek PM, Clark RS. Traumatic brain injury in infants and children: Mechanisms of secondary damage and treatment in the intensive care unit. Crit Care Clin 2003; 19(3): 529-49.
20. Truettner JS, Suzuki T, Dietrich WD. The effect of therapeutic hypothermia on the expression of inflammatory response genes following moderate traumatic brain injury in the rat. Brain Res Mol Brain Res 2005; 138(2): 124-34.
21. Whalen MJ, Carlos TM, Clark RS, Marion DW, DeKosky ST, Heineman S, et al. The effect of brain temperature on acute inflammation after traumatic brain injury in rats. J Neurotrauma 1997; 14(8): 561-72.
22. Chatzipanteli K, Alonso OF, Kraydieh S, Dietrich WD. Importance of posttraumatic hypothermia and hyperthermia on the inflammatory response after fluid percussion brain injury: Biochemical and immunocytochemical studies. J Cereb Blood Flow Metab 2000; 20(3): 531-42.
23. Marion DW, Penrod LE, Kelsey SF, Obrist WD, Kochanek PM, Palmer AM, et al. Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med 1997; 336(8): 540-6.
24. Metz C, Holzschuh M, Bein T, Woertgen C, Frey A, Frey I, et al. Moderate hypothermia in patients with severe head injury: Cerebral and extracerebral effects. J Neurosurg 1996; 85(4): 533-41.
25. Gal R, Cundrle I, Zimova I, Smrcka M. Mild hypothermia therapy for patients with severe brain injury. Clin Neurol Neurosurg 2002; 104(4): 318-21.
26. Jiang JY, Xu W, Li WP, Gao GY, Bao YH, Liang YM, et al. Effect of long-term mild hypothermia or short-term mild hypothermia on outcome of patients with severe traumatic brain injury. J Cereb Blood Flow Metab 2006; 26(6): 771-6.
27. Jiang J, Yu M, Zhu C. Effect of long-term mild hypothermia therapy in patients with severe traumatic brain injury: 1-year follow-up review of 87 cases. J Neurosurg 2000; 93(4): 546-9.
28. Qiu WS, Liu WG, Shen H, Wang WM, Hang ZL, Zhang Y, et al. Therapeutic effect of mild hypothermia on severe traumatic head injury. Chin J Traumatol 2005; 8(1): 27-32.
29. Peterson K, Carson S, Carney N. Hypothermia treatment for traumatic brain injury: A systematic review and meta-analysis. J Neurotrauma 2008; 25(1): 62-71.
30. Clifton GL, Miller ER, Choi SC, Levin HS, McCauley S, Smith KR Jr, et al. Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med 2001; 344(8): 556-63.
31. [Sydenham E, Roberts I, Alderson P. Hypothermia for traumatic head injury. Cochrane Database Syst Rev 2009; 15(2): CD001048.
32. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics--2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119(3): 480-6.
33. Hankey GJ, Warlow CP. Treatment and secondary prevention of stroke: Evidence, costs, and effects on individuals and populations. Lancet 1999; 354(9188): 1457-63.
34. Jian S, Yongming Q, Zhihua C, Yan C. Feasibility and safety of moderate hypothermia after acute ischemic stroke. Int J Dev Neurosci 2003; 21(6): 353-6.
35. Krieger DW, Yenari MA. Therapeutic hypothermia for acute ischemic stroke: What do laboratory studies teach us? Stroke 2004; 35(6): 1482-9.
36. Huang F, Zhou L. Effect of mild hypothermia on the changes of cerebral blood flow, brain blood barrier and neuronal injuries following reperfusion of focal cerebral ischemia in rats. Chin Med J (Engl) 1998; 111(4): 368-72.
37. Dietrich WD, Busto R, Halley M, Valdes I. The importance of brain temperature in alterations of the blood-brain barrier following cerebral ischemia. J Neuropathol Exp Neurol 1990; 49(5): 486-97.
38. Nagel S, Su Y, Horstmann S, Heiland S, Gardner H, Koziol J, et al. Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: Effects on BBB breakdown and MMP expression in the acute and subacute phase. Brain Res 2008; 1188: 198-206.
39. Baumann E, Preston E, Slinn J, Stanimirovic D. Post-ischemic hypothermia attenuates loss of the vascular basement membrane proteins, agrin and SPARC, and the blood-brain barrier disruption after global cerebral ischemia. Brain Res 2009; 1269: 185-97.
40. Kawai N, Kawanishi M, Okauchi M, Nagao S. Effects of hypothermia on thrombin-induced brain edema formation. Brain Res 2001; 895(1-2): 50-8.
41. Kawanishi M, Kawai N, Nakamura T, Luo C, Tamiya T, Nagao S, et al. Effect of delayed mild brain hypothermia on edema formation after intracerebral hemorrhage in rats. J Stroke Cerebrovasc Dis 2008; 17(4): 187-95.
42. Webster CM, Kelly S, Koike MA, Chock VY, Giffard RG, Yenari MA, et al. Inflammation and NFkappaB activation is decreased by hypothermia following global cerebral ischemia. Neurobiol Dis 2009; 33(2): 301-12.
43. Diestel A, Troeller S, Billecke N, Sauer IM, Berger F, Schmitt KR, et al. Mechanisms of hypothermia-induced cell protection mediated by microglial cells in vitro. Eur J Neurosci 2010; 31(5): 779-87.
44. Cao J, Xu J, Li W, Liu J. Influence of selective brain cooling on the expression of ICAM-1 mRNA and infiltration of PMNLs and monocytes/macrophages in rats suffering from global brain ischemia/reperfusion injury. Biosci Trends 2008; 2(6): 241-4.
45. Yenari M, Kitagawa K, Lyden P, Perez-Pinzon M. Metabolic downregulation: A key to successful neuroprotection? Stroke 2008; 39(10): 2910-7.
46. Koda Y, Tsuruta R, Fujita M, Miyauchi T, Kaneda K, Todani M, et al. Moderate hypothermia suppresses jugular venous superoxide anion radical, oxidative stress, early inflammation, and endothelial injury in forebrain ischemia/reperfusion rats. Brain Res 2010; 1311: 197-205.
47. Zhao H, Wang JQ, Shimohata T, Sun G, Yenari MA, Sapolsky RM, et al. Conditions of protection by hypothermia and effects on apoptotic pathways in a rat model of permanent middle cerebral artery occlusion. J Neurosurg 2007; 107(3): 636-41.
48. Zhao H, Shimohata T, Wang JQ, Sun G, Schaal DW, Sapolsky RM, et al. Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci 2005; 25(42): 9794-806.
49. Linares G, Mayer SA. Hypothermia for the treatment of ischemic and hemorrhagic stroke. Crit Care Med 2009; 37(7 Suppl): S243-9.
50. Liu L, Yenari MA. Clinical application of therapeutic hypothermia in stroke. Neurol Res 2009; 31(4): 331-5.
51. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, et al. Treatment of comatose survivors of out-ofhospital cardiac arrest with induced hypothermia. N Engl J Med 2002; 346(8): 557-63.
52. Batista LM, Lima FO, Januzzi JL Jr., Donahue V, Snydeman C, Greer DM. Feasibility and safety of combined percutaneous coronary intervention and therapeutic hypothermia following cardiac arrest. Resuscitation 2010; 81(4): 398-403.
53. Boysen G, Christensen H. Stroke severity determines body temperature in acute stroke. Stroke 2001;32(2): 413-7.
54. Lin SH, Chuang KL, Lin CC. Temporal patterns of body temperatures in the acute stage of stroke. Acta Neurol Taiwan 2006; 15(3): 177-83.
55. Berrouschot J, Sterker M, Bettin S, Koster J, Schneider D. Mortality of space-occupying ('malignant') middle cerebral artery infarction under conservative intensive care. Intensive Care Med 1998; 24(6): 620-3.
56. Milhaud D, Thouvenot E, Heroum C, Escuret E. Prolonged moderate hypothermia in massive hemispheric infarction: Clinical experience. J Neurosurg Anesthesiol 2005; 17(1): 49-53.
57. Lazzaro MA, Prabhakaran S. Induced hypothermia in acute ischemic stroke. Expert Opin Investig Drugs 2008; 17(8): 1161-74.
58. den Hertog H, van der Worp B, van Gemert M, Dippel D. Therapeutic hypothermia in acute ischemic stroke. Expert Rev Neurother 2007; 7(2): 155-64.
59. [den Hertog HM, van der Worp HB, Tseng MC, Dippel DW. Cooling therapy for acute stroke. Cochrane Database Syst Rev 2009; 1: CD001247.
60. Georgiadis D, Schwarz S, Aschoff A, Schwab S. Hemicraniectomy and moderate hypothermia in patients with severe ischemic stroke. Stroke 2002; 33(6): 1584-8.
61. Els T, Oehm E, Voigt S, Klisch J, Hetzel A, Kassubek J, et al. Safety and therapeutical benefit of hemicraniectomy combined with mild hypothermia in comparison with hemicraniectomy alone in patients with malignant ischemic stroke. Cerebrovasc Dis 2006; 21(1-2): 79-85.
62. Merenda A, DeGeorgia M. Craniectomy for acute ischemic stroke: How to apply the data to the bedside. Curr Opin Neurol 2010; 23(1): 53-8.
63. Winter CD, Adamides A, Rosenfeld JV. The role of decompressive craniectomy in the management of traumatic brain injury: A critical review. J Clin Neurosci 2005; 12(6): 619-23.
64. Pfefferkorn T, Eppinger U, Linn J, Birnbaum T, Herzog J, Straube A, et al. Long-term outcome after suboccipital decompressive craniectomy for malignant cerebellar infarction. Stroke 2009; 40(9): 3045-50.
65. Swiat M, Targosz-Gajniak M, Arkuszewski M, Wojtacha M, Bazowski P, Opala G, et al. Decompressive hemicraniectomy in ischaemic stroke. Neurol Neurochir Pol 2010; 44(2): 131-8.
66. Mattos JP, Joaquim AF, de Almeida JP, de Albuquerque LA, da Silva EG, Marenco HA, et al. Decompressive craniectomy in massive cerebral infarction. Arq Neuropsiquiatr 2010; 68(3): 339-45.
67. Hutchinson P, Timofeev I, Kirkpatrick P. Surgery for brain edema. Neurosurg Focus 2007; 22(5): E14.
68. Park J, Kim E, Kim GJ, Hur YK, Guthikonda M. External decompressive craniectomy including resection of temporal muscle and fascia in malignant hemispheric infarction. J Neurosurg 2009;110(1):101-5.
69. Doerfler A, Schwab S, Hoffmann TT, Engelhorn T, Forsting M. Combination of decompressive craniectomy and mild hypothermia ameliorates infarction volume after permanent focal ischemia in rats. Stroke 2001; 32(11): 2675-81.
70. Jieyong B, Zhong W, Shiming Z, Dai Z, Kato Y, Kanno T, et al. Decompressive craniectomy and mild hypothermia reduces infarction size and counterregulates Bax and Bcl-2 expression after permanent focal ischemia in rats. Neurosurg Rev 2006; 29(2): 168-72.
71. Szczygielski J, Mautes AE, Schwerdtfeger K, Steudel WI. The effects of selective brain hypothermia and decompressive craniectomy on brain edema after closed head injury in mice. Acta Neurochir Suppl 2010; 106: 225-9.
72. [Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell 2010; 140(6):9 18-34.
73. Lossinsky AS, Shivers RR. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Histol Histopathol 2004; 19(2): 535-64.
74. Bush TG, Puvanachandra N, Horner CH, Polito A, Ostenfeld T, Svendsen CN, et al. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 1999; 23(2): 297-308.
75. Stoll G, Jander S, Schroeter M. Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Adv Exp Med Biol 2002; 513: 87-113.
76. Prandini MN, Neves Filho A, Lapa AJ, Stavale JN. Mild hypothermia reduces polymorphonuclear leukocytes infiltration in induced brain inflammation. Arq Neuropsiquiatr 2005; 63(3B): 779-84.
77. Froehler MT, Ovbiagele B. Therapeutic hypothermia for acute ischemic stroke. Expert Rev Cardiovasc Ther 2010; 8(4): 593-603.
78. [Hoque N, Chakkarapani E, Liu X, Thoresen M. A comparison of cooling methods used in therapeutic hypothermia for perinatal asphyxia. Pediatrics 2010; 126(1): e124-30.
79. Barber PA, Hoyte L, Colbourne F, Buchan AM. Temperatureregulated model of focal ischemia in the mouse: A study with histopathological and behavioral outcomes. Stroke 2004; 35(7): 1720-5.
80. Liu Y, Barks JD, Xu G, Silverstein FS. Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke 2004; 35(6): 1460-5.
81. Yang XF, Ouyang Y, Kennedy BR, Rothman SM. Cooling blocks rat hippocampal neurotransmission by a presynaptic mechanism: Observations using 2-photon microscopy. J Physiol 2005; 567(Pt 1): 215-24.
82. Bohn DJ, Biggar WD, Smith CR, Conn AW, Barker GA. Influence of hypothermia, barbiturate therapy, and intracranial pressure monitoring on morbidity and mortality after near-drowning. Crit Care Med 1986; 14(6): 529-34.
83. Rohrer MJ, Natale AM. Effect of hypothermia on the coagulation cascade. Crit Care Med 1992; 20(10): 1402-5.
84. Wu X, Stezoski J, Safar P, Behringer W, Kentner R, Kochanek PM, et al. Systemic hypothermia, but not regional gut hypothermia, improves survival from prolonged hemorrhagic shock in rats. J Trauma 2002; 53(4): 654-62.
85. Hua Y, Hisano K, Morimoto Y. Effect of mild and moderate hypothermia on hypoxic injury in nearly pure neuronal culture. J Anesth 2010; 24(5): 726-32.
86. Fox JL, Vu EN, Doyle-Waters M, Brubacher JR, Abu-Laban R, Hu Z, et al. Prophylactic hypothermia for traumatic brain injury: A quantitative systematic review. CJEM 2010; 12(4): 355-64.
87. Salonia R, Empey P, Poloyac SM, Wisniewski SR, Klamerus M, Ozawa H, et al. Endothelin-1 is increased in cerebrospinal fluid and associated with unfavorable outcomes in children after severe traumatic brain injury. J Neurotrauma 2010; 27(10): 1819-25.
88. Colbourne F, Corbett D. Delayed postischemic hypothermia: A six month survival study using behavioral and histological assessments of neuroprotection. J Neurosci 1995; 15(11): 7250-60.
89. Gordan ML, Kellermann K, Blobner M, Nollert G, Kochs EF, Jungwirth B, et al. Fast rewarming after deep hypothermic circulatory arrest in rats impairs histologic outcome and increases NF{kappa}B expression in the brain. Perfusion 2010; 25(5): 349-54.
90. Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 2003; 4(11): 873-84.
91. Mackie K. Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol 2006; 46: 101-22.
92. Di Marzo V. Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 2008; 7(5): 438-55.
93. Bonfils PK, Reith J, Hasseldam H, Johansen FF. Estimation of the hypothermic component in neuroprotection provided by cannabinoids following cerebral ischemia. Neurochem Int 2006; 49(5): 508-18.
94. Mackie K. Signaling via CNS cannabinoid receptors. Mol Cell Endocrinol 2008; 286(1-2 Suppl 1): S60-5.
95. Stella N. Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia 2010; 58(9): 1017-30.
96. Cabral GA, Raborn ES, Griffin L, Dennis J, Marciano-Cabral F. CB2 receptors in the brain: Role in central immune function. Br J Pharmacol 2008; 153(2): 240-51.
97. Sagredo O, Gonzalez S, Aroyo I, Pazos MR, Benito C, Lastres-Becker I, et al. Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease. Glia 2009; 57(11): 1154-67.
98. Jin KL, Mao XO, Goldsmith PC, Greenberg DA. CB1 cannabinoid receptor induction in experimental stroke. Ann Neurol 2000; 48(2): 257-61.
99. Sinor AD, Irvin SM, Greenberg DA. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neurosci Lett 2000; 278(3): 157-60.
100. Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, et al. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci 1999; 19(8): 2987-95.
101. Braida D, Pozzi M, Sala M. CP 55,940 protects against ischemiainduced electroencephalographic flattening and hyperlocomotion in Mongolian gerbils. Neurosci Lett 2000; 296(2-3): 69-72.
102. Frost, J. M., Tietje, K., Dart, M. J., Meyer, M. D. Indoles are cannabinoid receptor ligands. US7560481 (2009) & US20090149501 (2009) & US7750039 (2010).
103. Lazzari, P., Rulu, S., Pinna, G. A., Murineddu, G. Pharmaceutical compounds. US20100105896A1 (2009) & US7659407 (2010).
104. Riether, D., Thomson, D. S., Wu, L., Zindell, R. M. Compounds which modulate The CB2 receptor. US20090275611 (2009) & WO2010077836 (2010).
105. Alanine, A., Bleicher, K., Guba, W., Haap, W., Kube, D., Luebbers, T., Plancher, J. M., Roche, O., Rogers-evans, M., Schneider, Gisbert., Zuegge, J. Benzodioxole derivatives. US7576088 (2009).
106. Yacovan, A., Grynszpan, F., Aizikovich, A., Brody, M. S., Barjoseph, A., Meilin, S. Benzofuran derivatives with therapeutic activities. US20090054376 (2009).
107. Kolasa, T., Frost, J. M., Patel, M. V., Latshaw, S. P., Perez- Medrano, A., Wang, X., Tietje, K. R., Peddi, S., Carroll, W. A. Novel compounds as cannabinoid receptor ligands. US20090247500 (2009).
108. Carroll, W. A., Frost, J. M., Latshaw, S. P., Kolasa, T., Tietje, K. R. M., Li, T., Peddi, S., Perez-Medrano, A., Patel, M. V., Wang, X. Novel compounds as cannabinoid receptor ligands. WO2009114566 (2009).
109. Dolle, R. E., Worm, K., Zhou, J. Q. Phenyl derivatives and methods of use. US7671052 (2010).
110. Carroll, W. A., Nelson, D. W., Perez-Medrano, A. Novel compounds as cannabinoid receptor ligands. WO2009009550 (2009).
111. Carroll, W. A., Dart, M. J., Perez-Medrano, A., Nelson, D. W. Novel compounds as cannabinoid receptor ligands. US20090018114 (2009).
112. Meyer, M. D., Dart, M. J., Carroll, W. A., Patel, M. V., Kolasa, T., Wang, X. Novel compounds as cannabinoid receptor ligands. US20080255123 (2008).
113. Carroll, W. A., Dart, M. J., Perez-Medrano, A., Nelson, D. W., Li, T., Peddi, S., Frost, J., Kolasa, T., Liu, B., Latshaw, S. P., Wang, X. Novel compounds as cannabinoid receptor ligands. US20090105306 (2009).
114. Carroll, W. A., Meyer, M. D., Perez-Medrano, A., Dart, M. J., Nelson, D. W. Novel compounds as cannabinoid receptor ligands. WO2009048936 (2009).
115. Torrens Jover, A., Yenes-minguez, S. Prodrugs of pyrazoline compounds, their preparation and use as medicaments. US20080300278 (2008).
116. Makriyannis, A., Liu, Q., Zvonok, A. M. Heteroindanes: A new class of potent cannabimimetic ligands. US7666867 (2010).
117. Beckett, P. R., Foster, R., Henault, C., Ralbovsky, J. L., Gauss, C. M., Gustafson, G. R., Luo, R. Z., Campbell, A., Shelekhin, T. E., Zablocki, M. E. Substituted Imidazoheterocycles. US20090149450 (2009).
118. Carroll, W. A., Dart, M. J., Frost, J. M., Kolasa, T., Latshaw, S., Liu, B., Patel, M. V., Perez-medrano, A., Wang, X. Imine derivatives as cannabinoid receptor ligands. WO2010019547 (2010).
119. Carroll, W. A., Dart, M. J., Frost, J. M., Kolasa, T., Latshaw, S. P., Liu, B., Patel, M. V., Perez-Medrano, A., Wang, X. Novel compounds as cannabinoid receptor ligands. US20100041720 (2010).
120. Carroll, W. A., Dart, M. J., Kolasa, T., Li, T., Nelson, D. W., Patel, M. V., Peddi, S., Perez-Medrano, A., Wang, X. Novel compounds as cannabinoid receptor ligands. US20090023789 (2009).
121. Carroll, W. A., Meyer, M. D. Novel compounds as cannabinoid receptor ligands. WO2008130953 (2008).
122. Carroll, W. A., Kolasa, T., Li, T., Nelson, D. W., Perez-Medrano, A., Patel, M., Wang, X., Peddi, S. Novel compounds as cannabinoid receptor ligands. WO2010054024 (2010).
123. Carroll, W. A., Dart, M. J., Frost, J. M., Kolasa, T., Li, T., Liu, B., Perez-medrano, A., Patel, M., Wang, X., Peddi, S. Novel compounds as cannabinoid receptor ligands. WO2010028338 (2010) & US20100063022 (2010).
124. Florjancic, A. S., Dart, M. J., Ryther, K. B., Perez-medrano, A., Carroll, W. A., Patel, M. V., Tietje, K. R., Li, T., Kolasa, T., Gallagher, M. E., Peddi, S., Frost, J. M., Nelson, D. W. Novel compounds as cannabinoid receptor ligands and uses thereof. WO2008121558 (2008) & WO2009067613 (2009) & US20100093814 (2010).
125. [Rawls SM, Cabassa J, Geller EB, Adler MW. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5- dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenylcarbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia. J Pharmacol Exp Ther 2002; 301(3): 963-8. & WO2009075691 (2009).
126. Zindell, R., Riether, D., Thomson, D. S., Hickey, E. R., Mushi, I., Ermann, M. Compounds which modulate the CB2 receptor. US7595397 (2006).
127. Carroll, W. A., Dart, M. J., Frost, J. M., Latshaw, S. P., Kolasa, T., Li, T., Peddi, S., Liu, B., Perez-Medrano, A., Patel, M., Wang, X., Nelson, D. W. Novel compounds as cannabinoid receptor ligands. WO2010033543 (2010) & US20100069348 (2010) & US20100069349 (2010) & US7745440 (2010).
128. Okuyama, M. M., Selwood, D., Visintin, C., Baker, D., Pryce, G. Modulators of cannabinoid receptor. EP1745011 (2009) & WO2009095752 (2009).
129. Makriyannis, A., Khanolkar, A. Peripheral cannabinoid receptor (CB2) selective ligands. US7741365 (2010).
130. Mayweg, A., Marty, H. P., Mueller, W., Narquizian, R., Neidhart, W., Pflieger, P., Roever, S. CB1 receptor inverse agonists. EP1583742 (2009) & US7579369 (2009).
131. Mayweg, A., Narquizian, R., Pflieger, P., Roever, S. Heterocyclic cannabinoid receptor antagonists. US7563910 (2009).
132. Mayweg, A., Naroquizian, R., Pelieger, P., Roever, S. Pyrrole or imidazole amides for treating obesity. EP1749002 (2009).
133. Gilbert, E. J., Greenlee, W. J., Li, S. W., Miller, M. W., Scott, J. D., Stamford, A., Celly, C. S. Substituted piperazines as CB1 antagonists. WO2009005671 (2009).
134. Gilbert, E. J., Miller, M. W., Scott, J. D., Demong, D. E., Stamford, A., Greenlee, W. J., Celly, C. S. Substituted piperazines as CB1 antagonists. WO2009005645 (2009). & WO2009005646 (2009).
135. Carroll, W. A., Dart, M. J., Perez-Medrano, A., Frost, J. M., Peddi, S. Novel compounds as cannabinoid receptor ligands. US20080287510 (2008).
136. Kolasa, T., Frost, J. M., Patel, M. V., Latshaw, S. P., Perezmedrano, A., Wang, X., Peddi, S., Carroll, W. A., Dart, M. J. Novel compounds as cannabinoid receptor ligands. US20080242654 (2008).
137. Dart, M. J., Carroll, W. A., Patel, M. V., Frost, J.M., Peddi, S., Latshaw, S. P., Kolasa, T., Perez-Medrano, A., Wang X. 1, 3- Thiazol-2 (3H) -ylidene compounds as cannabinoid receptor ligands. MX2009010363 (2009).
138. Weber, U. J., Gotfredsen, J. Use of a combination of hypothermia inducing drugs. WO2009124552 (2009).
139. Yacovan, A., Bar-joseph, A., Meilin, S., Amselem, S. Orally effective cannabinoid analogs. US20090068143 (2009).
140. Viscomi MT, Oddi S, Latini L, Bisicchia E, Maccarrone M, Molinari M, et al. The endocannabinoid system: A new entry in remote cell death mechanisms. Exp Neurol 2010; 224(1): 56-65.
141. Rawls SM, Tallarida RJ, Kon DA, Geller EB, Adler MW. GABAA receptors modulate cannabinoid-evoked hypothermia. Pharmacol Biochem Behav 2004; 78(1): 83-91.
142. Gonzalez B, Paz F, Floran L, Aceves J, Erlij D, Floran B, et al. Cannabinoid agonists stimulate [3H]GABA release in the globus pallidus of the rat when G(i) protein-receptor coupling is restricted: Role of dopamine D2 receptors. J Pharmacol Exp Ther 2009; 328(3): 822-8.
143. Sulcova E, Mechoulam R, Fride E. Biphasic effects of anandamide. Pharmacol Biochem Behav 1998; 59(2): 347-52.
144. Berke, L.D. Convective hyperthermia article. US5165400 (1992).
145. Clifton, G.L., Miller, E.R. Heat transfer blanket for and method of controlling a patient's temperature. US6375673 (2002).
146. Flick, R.E., Jusiak, J.T. Supported hypo/hyperthemia pad. US6871365 (2005).
147. Kushnir, I. System and method for heat control of a living body. US6508831 (2003).
148. Laish-Farkash A, Matetzky S, Kassem S, Haj-Iahia H, Hod H. Therapeutic hypothermia for comatose survivors after cardiac arrest. Isr Med Assoc J 2007; 9(4): 252-6.
149. Evans, S.M., Aliberto, A.C., Worthen, W.J. Kit of parts including a heat exchange catheter for treating heart malady. US20030060761 (2003).
150. Heard KJ, Peberdy MA, Sayre MR, Sanders A, Geocadin RG, Dixon SR, et al. A randomized controlled trial comparing the Arctic Sun to standard cooling for induction of hypothermia after cardiac arrest. Resuscitation 2010; 81(1): 9-14.
151. Georgiadis D, Schwarz S, Kollmar R, Schwab S. Endovascular cooling for moderate hypothermia in patients with acute stroke: First results of a novel approach. Stroke 2001; 32(11): 2550-3.
152. Mack WJ, Huang J, Winfree C, Kim G, Oppermann M, Dobak J, et al. Ultrarapid, convection-enhanced intravascular hypothermia: A feasibility study in nonhuman primate stroke. Stroke 2003; 34(8): 1994-9.
153. Bernard S, Buist M, Monteiro O, Smith K. Induced hypothermia using large volume, ice-cold intravenous fluid in comatose survivors of out-of-hospital cardiac arrest: A preliminary report. Resuscitation 2003; 56(1): 9-13.
154. Noda, W., Evans, S., Jones, M. Indwelling heat exchange heat pipe catheter and method of using same. US6530946 (2003).
155. Balding, D.P., Worthen, W.J. Method and apparatus for cardiopulmonary bypass patient temperature control. US6572640 (2003).
156. Al-Senani FM, Graffagnino C, Grotta JC, Saiki R, Wood D, Chung W, et al. A prospective, multicenter pilot study to evaluate the feasibility and safety of using the CoolGard System and Icy catheter following cardiac arrest. Resuscitation 2004; 62(2): 143-50.
157. Hinz J, Rosmus M, Popov A, Moerer O, Frerichs I, Quintel M, et al. Effectiveness of an intravascular cooling method compared with a conventional cooling technique in neurologic patients. J Neurosurg Anesthesiol 2007; 19(2): 130-5.
158. Badjatia N. Celsius Control system. Neurocrit Care 2004; 1(2): 201-3.
159. Prunet B, Lacroix G, Bordes J, Poyet R, D'Aranda E, Goutorbe P, et al. Catheter related venous thrombosis with cooling and warming catheters: Two case reports. Cases J 2009; 2: 8857.
160. Boller M, Lampe JW, Katz JM, Barbut D, Becker LB. Feasibility of intra-arrest hypothermia induction: A novel nasopharyngeal approach achieves preferential brain cooling. Resuscitation 2010; 81(8): 1025-30.
161. Busch HJ, Eichwede F, Fodisch M, Taccone FS, Wobker G, Schwab T, et al. Safety and feasibility of nasopharyngeal evaporative cooling in the emergency department setting in survivors of cardiac arrest. Resuscitation 2010; 81(8): 943-9.
162. Castren M, Nordberg P, Svensson L, Taccone F, Vincent JL, Desruelles D, et al. Intra-arrest transnasal evaporative cooling: A randomized, prehospital, multicenter study (PRINCE: Pre-ROSC IntraNasal Cooling Effectiveness). Circulation 2010; 122(7): 729-36.
163. Wagner KR, Zuccarello M. Local brain hypothermia for neuroprotection in stroke treatment and aneurysm repair. Neurol Res 2005; 27(3): 238-45.
164. Bigio, M.R.D., Shulyakov, A.V. Device to reduce brain edema by surface dialysis and cooling. US20090048582 (2009).
165. King C, Robinson T, Dixon CE, Rao GR, Larnard D, Nemoto CE, et al. Brain temperature profiles during epidural cooling with the chillerpad in a monkey model of traumatic brain injury. J Neurotrauma 2010; 27(10): 1895-903.
166. Hato N, Hyodo J, Takeda S, Takagi D, Okada M, Hakuba N, et al. Local hypothermia in the treatment of idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 2010; 37(5): 626-30.
167. Federico A. Therapeutic hypothermia: A case study. J Perianesth Nurs 2010; 25(3): 141-5.
168. Bourdages M, Bigras JL, Farrell CA, Hutchison JS, Lacroix J. Cardiac arrhythmias associated with severe traumatic brain injury and hypothermia therapy. Pediatr Crit Care Med 2010; 11(3): 408-14.
169. Zhao W, Alonso OF, Loor JY, Busto R, Ginsberg MD. Influence of early posttraumatic hypothermia therapy on local cerebral blood flow and glucose metabolism after fluid-percussion brain injury. J Neurosurg 1999; 90(3): 510-9.